The recent sale of shares in memory chip leader Gigadevice Semiconductor Inc. (SHSE: 603986) by China Life Insurance Company Limited (SHSE: 601628) appears to be a disciplined portfolio rebalancing move, executed as the stock experienced significant volatility following a major rally.

On the evening of July 20, the insurer announced that eight of its asset management plans had collectively sold approximately 1.1097 million shares of Gigadevice, raising about 6.82 billion yuan. This transaction was completed on July 8, with a selling price range between 611.46 yuan and 624.61 yuan per share. The company stated that such adjustments to holdings in individual stocks are routine investment actions based on portfolio allocation needs.

Gigadevice is one of the most sought-after memory chip stocks on the A-share market. Starting from around 55 yuan in 2024, its price surged nearly 14-fold over two and a half years, reaching an all-time intraday high of 843.38 yuan on July 1, 2026. Following a risk warning announcement from the company on June 29, the stock entered a correction phase, declining for six consecutive trading days. By July 8, the closing price had fallen to 603.17 yuan, representing a roughly 30% pullback from the peak—the precise timing of China Life's sale. The stock continued to decline, closing at 432.30 yuan on July 20, nearly halving from its high.

The precision of the sale timing suggests it was not a hasty decision but a calculated move. On the same day, China Life also announced a separate, significant market action. Its asset management arm reported net purchases of over 10 billion yuan in A-shares and related fund equity assets, targeting broad-based ETFs and key sectors like the modern industrial system and new quality productive forces. This move was framed as part of seizing strategic allocation opportunities and increasing equity exposure.

China Life's actions were part of a broader coordinated effort, with other major insurers like PICC, Ping An, CPIC, and New China Life also voicing support for the capital market. This followed announcements from other state-backed entities about substantial stock purchases to stabilize the market.

While selling Gigadevice while simultaneously injecting billions into the market may seem contradictory on the surface, a longer-term view of the first half of 2026 provides a clearer picture. The scale of the Gigadevice transaction is relatively small within China Life's multi-trillion yuan investment portfolio, and the eight asset management plans involved were not among the top ten shareholders of the company as of the first quarter of 2026.

The eight plans, established in cooperation with asset managers like Harvest Fund and ChinaAMC, cover balanced and growth strategies across various account types. Industry insiders view this coordinated, multi-strategy action as characteristic of a systematic portfolio reallocation. When a stock's price surge causes its weight in a portfolio to exceed a predetermined range, selling to restore the target allocation is a standard practice in insurance fund management.

This sale appears to be a disciplined rebalancing triggered by the stock's performance—a systematic asset allocation decision to realize gains and manage risk exposure. This tactical profit-taking at the individual stock level coexists with a strategic commitment to increase market exposure, both operating within the same overarching investment framework.

China Life's strong half-year performance, with net profit surging 215% to 235% year-over-year, was largely driven by the extreme structural rally in the technology sector during the second quarter. Under new accounting standards, the sharp rise in tech stocks directly translated into significant profits. The company attributed its performance to optimized asset allocation and successful investments in areas like new quality productive forces.

This dual approach of tactical execution and strategic positioning is further illustrated by the actions of Honghu Fund, a joint venture equally owned by China Life and New China Life. In the first quarter of 2026, Honghu's funds adjusted their holdings, selling cyclical stocks like Shaanxi Coal and buying into consumer and financial leaders like Kweichow Moutai and ICBC. This "barbell strategy" of holding high-dividend assets for stability while using quality growth stocks for offense represents the strategic, long-term deployment of patient capital.

Portfolio rebalancing is a standard, ongoing practice for large, long-term institutional investors globally, aimed at managing risk and optimizing risk-adjusted returns. It is not a signal of bearishness on a particular asset but a mechanism to pull a portfolio back to its strategic target allocation.

Major global asset managers like BlackRock and Vanguard treat rebalancing as a core tool. Vanguard's research indicates that while a perfectly rebalanced portfolio may slightly underperform a "let-it-ride" strategy in pure return terms, it significantly reduces volatility, better matching the portfolio's risk profile to the investor's tolerance.

The world's largest sovereign wealth fund, Norway's Government Pension Fund Global (GPFG), operates under strict rebalancing rules triggered when asset class weights deviate from their strategic benchmarks. Its CEO has described buying or selling based on these rules as a matter of discipline, not judgment—a discipline that has delivered consistent returns over decades.

Even traditional public pension funds are evolving their approaches. The California Public Employees' Retirement System (CalPERS) recently shifted from a traditional strategic asset allocation model to a Total Portfolio Approach, simplifying its management to focus on the overall risk, return, and liquidity of the entire fund.

The consistency among global long-term institutional investors is striking. While markets are unpredictable, rebalancing is a tool to manage risk and maintain a portfolio's strategic course. For large insurance asset managers, the ability to balance tactical discipline with strategic conviction, individual risk control with broader market responsibility, is essential. Adhering to investment discipline at the stock level, executing strategic allocation at the market level, and embracing new growth themes at the portfolio level are all different tactics within a unified investment framework.